Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR).
Sakai K, Tsuboi M, Kenmotsu H, Yamanaka T, Takahashi T, Goto K, Daga H, Ohira T, Ueno T, Aoki T, Nakagawa K, Yamazaki K, Hosomi Y, Kawaguchi K, Okumura N, Takiguchi Y, Sekine A, Haruki T, Yamamoto H, Sato Y, Akamatsu H, Seto T, Saeki S, Sugio K, Nishio M, Okabe K, Yamamoto N, Nishio K.
Sakai K, et al. Among authors: aoki t.
Cancer Sci. 2021 Jan;112(1):388-396. doi: 10.1111/cas.14730. Epub 2020 Nov 30.
Cancer Sci. 2021.
PMID: 33185928
Free PMC article.
Clinical Trial.